Agenus
AGEN
#8939
Rank
S$0.17 B
Marketcap
S$5.26
Share price
-2.64%
Change (1 day)
14.15%
Change (1 year)

Agenus (AGEN) - Total assets

Total assets on the balance sheet as of September 2025 : S$0.30 Billion

According to Agenus 's latest financial reports the company's total assets are S$0.30 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Agenus - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31S$0.30 B-25.81%
2023-12-31S$0.41 B-25.22%
2022-12-31S$0.55 B-11.99%
2021-12-31S$0.62 B121.97%
2020-12-31S$0.28 B35.51%
2019-12-31S$0.20 B12.38%
2018-12-31S$0.18 B0.67%
2017-12-31S$0.18 B-18.53%
2016-12-31S$0.22 B-33.69%
2015-12-31S$0.34 B247.95%
2014-12-31S$98.47 M123.12%
2013-12-31S$44.13 M24.06%
2012-12-31S$35.57 M38.69%
2011-12-31S$25.65 M-35.57%
2010-12-31S$39.81 M-38.18%
2009-12-31S$64.4 M-20.75%
2008-12-31S$81.26 M26.8%
2007-12-31S$64.08 M-42.71%
2006-12-31S$0.11 B-35.49%
2005-12-31S$0.17 B-20.11%
2004-12-31S$0.21 B-8.79%
2003-12-31S$0.23 B54.01%
2002-12-31S$0.15 B-10.76%
2001-12-31S$0.17 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Merck
MRK
S$167.85 B 55,287.34%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
S$106.84 B 35,155.91%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
S$249.83 B 82,338.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
S$0.84 B 177.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$125.54 B 41,324.85%๐Ÿ‡บ๐Ÿ‡ธ USA